| UniProt ID | ARFP1_HUMAN | |
|---|---|---|
| UniProt AC | P53367 | |
| Protein Name | Arfaptin-1 | |
| Gene Name | ARFIP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 373 | |
| Subcellular Localization | ||
| Protein Description | Putative target protein of ADP-ribosylation factor.. | |
| Protein Sequence | MAQESPKNSAAEIPVTSNGEVDDSREHSFNRDLKHSLPSGLGLSETQITSHGFDNTKEGVIEAGAFQGSPAPPLPSVMSPSRVAASRLAQQGSDLIVPAGGQRTQTKSGPVILADEIKNPAMEKLELVRKWSLNTYKCTRQIISEKLGRGSRTVDLELEAQIDILRDNKKKYENILKLAQTLSTQLFQMVHTQRQLGDAFADLSLKSLELHEEFGYNADTQKLLAKNGETLLGAINFFIASVNTLVNKTIEDTLMTVKQYESARIEYDAYRTDLEELNLGPRDANTLPKIEQSQHLFQAHKEKYDKMRNDVSVKLKFLEENKVKVLHNQLVLFHNAIAAYFAGNQKQLEQTLKQFHIKLKTPGVDAPSWLEEQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAQESPKNS ------CCCCCCCCC | 23.11 | 21406692 | |
| 5 (in isoform 2) | Phosphorylation | - | 29.15 | - | |
| 5 | Phosphorylation | ---MAQESPKNSAAE ---CCCCCCCCCCCC | 29.15 | 23401153 | |
| 9 | Phosphorylation | AQESPKNSAAEIPVT CCCCCCCCCCCCCCC | 34.67 | 22617229 | |
| 16 | Phosphorylation | SAAEIPVTSNGEVDD CCCCCCCCCCCCCCC | 15.89 | 23401153 | |
| 17 | Phosphorylation | AAEIPVTSNGEVDDS CCCCCCCCCCCCCCC | 42.97 | 23663014 | |
| 24 (in isoform 2) | Phosphorylation | - | 34.80 | - | |
| 24 | Phosphorylation | SNGEVDDSREHSFNR CCCCCCCCHHHCCCH | 34.80 | 25159151 | |
| 28 (in isoform 2) | Phosphorylation | - | 21.33 | - | |
| 28 | Phosphorylation | VDDSREHSFNRDLKH CCCCHHHCCCHHHHH | 21.33 | 25159151 | |
| 34 | Ubiquitination | HSFNRDLKHSLPSGL HCCCHHHHHCCCCCC | 35.12 | - | |
| 36 | Phosphorylation | FNRDLKHSLPSGLGL CCHHHHHCCCCCCCC | 40.15 | 22617229 | |
| 36 (in isoform 2) | Phosphorylation | - | 40.15 | - | |
| 39 | Phosphorylation | DLKHSLPSGLGLSET HHHHCCCCCCCCCCH | 52.52 | 23401153 | |
| 39 (in isoform 2) | Phosphorylation | - | 52.52 | - | |
| 44 | Phosphorylation | LPSGLGLSETQITSH CCCCCCCCCHHHEEC | 36.48 | 22617229 | |
| 46 | Phosphorylation | SGLGLSETQITSHGF CCCCCCCHHHEECCC | 23.15 | 25693802 | |
| 49 | Phosphorylation | GLSETQITSHGFDNT CCCCHHHEECCCCCC | 12.59 | 23403867 | |
| 50 | Phosphorylation | LSETQITSHGFDNTK CCCHHHEECCCCCCC | 24.20 | 23403867 | |
| 56 | Phosphorylation | TSHGFDNTKEGVIEA EECCCCCCCCCEEEE | 32.11 | 23403867 | |
| 69 | Phosphorylation | EAGAFQGSPAPPLPS EECCCCCCCCCCCCC | 13.70 | 29255136 | |
| 76 | Phosphorylation | SPAPPLPSVMSPSRV CCCCCCCCCCCHHHH | 37.83 | 29255136 | |
| 76 (in isoform 2) | Phosphorylation | - | 37.83 | 25159151 | |
| 78 | Sulfoxidation | APPLPSVMSPSRVAA CCCCCCCCCHHHHHH | 5.98 | 30846556 | |
| 79 | Phosphorylation | PPLPSVMSPSRVAAS CCCCCCCCHHHHHHH | 19.98 | 29255136 | |
| 81 | Phosphorylation | LPSVMSPSRVAASRL CCCCCCHHHHHHHHH | 31.89 | 29255136 | |
| 86 (in isoform 2) | Ubiquitination | - | 20.35 | 21890473 | |
| 86 | Phosphorylation | SPSRVAASRLAQQGS CHHHHHHHHHHHCCC | 20.35 | 23090842 | |
| 93 | Phosphorylation | SRLAQQGSDLIVPAG HHHHHCCCCEEECCC | 25.55 | 25693802 | |
| 100 (in isoform 2) | Phosphorylation | - | 27.05 | - | |
| 104 | Phosphorylation | VPAGGQRTQTKSGPV ECCCCCCCCCCCCCE | 32.47 | 28555341 | |
| 107 | Ubiquitination | GGQRTQTKSGPVILA CCCCCCCCCCCEEEE | 43.53 | - | |
| 108 | Phosphorylation | GQRTQTKSGPVILAD CCCCCCCCCCEEEEH | 52.28 | 21815630 | |
| 118 | Ubiquitination | VILADEIKNPAMEKL EEEEHHCCCHHHHHH | 55.63 | 21906983 | |
| 118 (in isoform 1) | Ubiquitination | - | 55.63 | 21890473 | |
| 124 | Ubiquitination | IKNPAMEKLELVRKW CCCHHHHHHHHHHHH | 33.89 | - | |
| 124 | 2-Hydroxyisobutyrylation | IKNPAMEKLELVRKW CCCHHHHHHHHHHHH | 33.89 | - | |
| 132 | Phosphorylation | LELVRKWSLNTYKCT HHHHHHHCCCHHHHH | 18.12 | 22167270 | |
| 135 | Phosphorylation | VRKWSLNTYKCTRQI HHHHCCCHHHHHHHH | 29.65 | 22167270 | |
| 136 | Phosphorylation | RKWSLNTYKCTRQII HHHCCCHHHHHHHHH | 11.73 | 23403867 | |
| 144 | Phosphorylation | KCTRQIISEKLGRGS HHHHHHHHHHHCCCC | 30.24 | 24719451 | |
| 146 | Acetylation | TRQIISEKLGRGSRT HHHHHHHHHCCCCCE | 49.83 | 25953088 | |
| 146 | 2-Hydroxyisobutyrylation | TRQIISEKLGRGSRT HHHHHHHHHCCCCCE | 49.83 | - | |
| 146 | Ubiquitination | TRQIISEKLGRGSRT HHHHHHHHHCCCCCE | 49.83 | - | |
| 172 | Phosphorylation | LRDNKKKYENILKLA HHCCHHHHHHHHHHH | 24.08 | 22210691 | |
| 173 | Ubiquitination | RDNKKKYENILKLAQ HCCHHHHHHHHHHHH | 46.83 | 21890473 | |
| 180 | Ubiquitination | ENILKLAQTLSTQLF HHHHHHHHHHHHHHH | 54.10 | - | |
| 192 | Phosphorylation | QLFQMVHTQRQLGDA HHHHHHHHHHHHHHH | 17.65 | 22210691 | |
| 221 (in isoform 2) | Phosphorylation | - | 34.64 | - | |
| 222 | Ubiquitination | GYNADTQKLLAKNGE CCCHHHHHHHHHCCC | 47.78 | - | |
| 249 | Phosphorylation | VNTLVNKTIEDTLMT HHHHHCHHHHHHHHH | 25.13 | 22210691 | |
| 253 | Phosphorylation | VNKTIEDTLMTVKQY HCHHHHHHHHHHHHH | 12.97 | 20068231 | |
| 255 | Sulfoxidation | KTIEDTLMTVKQYES HHHHHHHHHHHHHHH | 4.37 | 21406390 | |
| 256 | Phosphorylation | TIEDTLMTVKQYESA HHHHHHHHHHHHHHC | 27.88 | 22210691 | |
| 258 | Ubiquitination | EDTLMTVKQYESARI HHHHHHHHHHHHCCC | 37.69 | - | |
| 272 | Phosphorylation | IEYDAYRTDLEELNL CEECEECCCHHHCCC | 32.06 | 19060867 | |
| 289 | Ubiquitination | RDANTLPKIEQSQHL CCCCCCHHHHHHHHH | 63.09 | - | |
| 293 | Phosphorylation | TLPKIEQSQHLFQAH CCHHHHHHHHHHHHH | 13.53 | 30622161 | |
| 301 | Ubiquitination | QHLFQAHKEKYDKMR HHHHHHHHHHHHHHH | 59.94 | - | |
| 304 | Phosphorylation | FQAHKEKYDKMRNDV HHHHHHHHHHHHCCH | 23.14 | - | |
| 316 | Ubiquitination | NDVSVKLKFLEENKV CCHHHHHHHHHHCCC | 42.03 | - | |
| 321 (in isoform 2) | Ubiquitination | - | 45.07 | 21890473 | |
| 321 | Ubiquitination | KLKFLEENKVKVLHN HHHHHHHCCCCEEHH | 45.07 | 21890473 | |
| 322 | Ubiquitination | LKFLEENKVKVLHNQ HHHHHHCCCCEEHHH | 46.87 | - | |
| 322 | 2-Hydroxyisobutyrylation | LKFLEENKVKVLHNQ HHHHHHCCCCEEHHH | 46.87 | - | |
| 353 (in isoform 1) | Ubiquitination | - | 55.06 | 21890473 | |
| 353 | Ubiquitination | KQLEQTLKQFHIKLK HHHHHHHHHHCHHCC | 55.06 | 21890473 | |
| 360 | Ubiquitination | KQFHIKLKTPGVDAP HHHCHHCCCCCCCCC | 47.90 | - | |
| 361 | Phosphorylation | QFHIKLKTPGVDAPS HHCHHCCCCCCCCCH | 35.39 | 28355574 | |
| 368 | Phosphorylation | TPGVDAPSWLEEQ-- CCCCCCCHHHHCC-- | 46.11 | 26552605 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARFP1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARFP1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ARF3_HUMAN | ARF3 | physical | 10413101 | |
| DNM1L_HUMAN | DNM1L | physical | 22863883 | |
| IDE_HUMAN | IDE | physical | 22863883 | |
| LC7L2_HUMAN | LUC7L2 | physical | 22863883 | |
| ANM3_HUMAN | PRMT3 | physical | 22863883 | |
| PSMG3_HUMAN | PSMG3 | physical | 22863883 | |
| SC24A_HUMAN | SEC24A | physical | 22863883 | |
| GLYM_HUMAN | SHMT2 | physical | 22863883 | |
| STAT3_HUMAN | STAT3 | physical | 22863883 | |
| AACS_HUMAN | AACS | physical | 26344197 | |
| AK1A1_HUMAN | AKR1A1 | physical | 26344197 | |
| ATOX1_HUMAN | ATOX1 | physical | 26344197 | |
| ECH1_HUMAN | ECH1 | physical | 26344197 | |
| FLNB_HUMAN | FLNB | physical | 26344197 | |
| LYPA1_HUMAN | LYPLA1 | physical | 26344197 | |
| PA1B2_HUMAN | PAFAH1B2 | physical | 26344197 | |
| PDCD6_HUMAN | PDCD6 | physical | 26344197 | |
| PGM2L_HUMAN | PGM2L1 | physical | 26344197 | |
| DHPR_HUMAN | QDPR | physical | 26344197 | |
| STIP1_HUMAN | STIP1 | physical | 26344197 | |
| TBCA_HUMAN | TBCA | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-69; SER-79 AND SER-132,AND MASS SPECTROMETRY. | |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-272 AND THR-361, ANDMASS SPECTROMETRY. | |